CBZ vs. SLNO
Compare and contrast key facts about CBIZ, Inc. (CBZ) and Soleno Therapeutics, Inc. (SLNO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CBZ or SLNO.
Key characteristics
| CBZ | SLNO | |
|---|---|---|
| YTD Return | 25.56% | 38.34% |
| 1Y Return | 35.24% | 146.48% |
| 3Y Return (Ann) | 25.87% | 69.54% |
| 5Y Return (Ann) | 24.41% | 19.15% |
| 10Y Return (Ann) | 24.45% | -15.56% |
| Sharpe Ratio | 1.19 | 2.53 |
| Sortino Ratio | 1.55 | 3.09 |
| Omega Ratio | 1.29 | 1.36 |
| Calmar Ratio | 1.50 | 1.58 |
| Martin Ratio | 3.44 | 12.29 |
| Ulcer Index | 11.26% | 12.38% |
| Daily Std Dev | 32.42% | 60.27% |
| Max Drawdown | -96.16% | -99.86% |
| Current Drawdown | -8.64% | -91.52% |
Fundamentals
| CBZ | SLNO | |
|---|---|---|
| Market Cap | $3.92B | $2.47B |
| EPS | $2.37 | -$2.79 |
| PEG Ratio | 1.30 | 0.00 |
| Total Revenue (TTM) | $1.68B | $3.45M |
| Gross Profit (TTM) | $231.27M | $1.97M |
| EBITDA (TTM) | $198.10M | -$133.09M |
Correlation
The correlation between CBZ and SLNO is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CBZ vs. SLNO - Performance Comparison
In the year-to-date period, CBZ achieves a 25.56% return, which is significantly lower than SLNO's 38.34% return. Over the past 10 years, CBZ has outperformed SLNO with an annualized return of 24.45%, while SLNO has yielded a comparatively lower -15.56% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CBZ vs. SLNO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for CBIZ, Inc. (CBZ) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CBZ vs. SLNO - Dividend Comparison
Neither CBZ nor SLNO has paid dividends to shareholders.
Drawdowns
CBZ vs. SLNO - Drawdown Comparison
The maximum CBZ drawdown since its inception was -96.16%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for CBZ and SLNO. For additional features, visit the drawdowns tool.
Volatility
CBZ vs. SLNO - Volatility Comparison
CBIZ, Inc. (CBZ) has a higher volatility of 10.51% compared to Soleno Therapeutics, Inc. (SLNO) at 8.13%. This indicates that CBZ's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CBZ vs. SLNO - Financials Comparison
This section allows you to compare key financial metrics between CBIZ, Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities